Investing.com - Financial Markets Worldwide
Open in App

Galderma Group AG (GALD)

Switzerland
Symbol
Exchange
Currency
GALD·Switzerland·CHF
1GALD·Milan·EUR
GALD·Vienna·EUR
Currency in CHF
154.95
+1.25(+0.81%)
Closed·

GALD Income Statement

Period Ending:
2021
31/12
2022
31/12
2023
31/12
2024
31/12
2025
31/12
Total Revenues
3,4453,823.94,1174,4405,241
Total Revenues Growth
-+11%+7.66%+7.85%+18.04%
Cost Of Revenues
1,033.91,1941,2321,3551,632
Gross Profit
2,411.12,629.92,8853,0853,609
Gross Profit Growth
-+9.07%+9.7%+6.93%+16.99%
Gross Profit Margin %
69.99%68.78%70.08%69.48%68.86%
Other Operating Expenses, Total
2,061.62,2292,2792,4142,724
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
-+8.12%+2.24%+5.92%+12.84%
342.6315.9287260245
1,711.31,9081,9902,1512,490
7.75.123-11
Operating Income
349.5400.9606671885
Operating Income Growth
-+14.71%+51.16%+10.73%+31.89%
EBIT Margin %
10.15%10.48%14.72%15.11%16.89%
Net Interest Expenses
-352.7-398.4-555-340-160
Net Interest Expenses Growth
--12.96%-39.31%+38.74%+52.94%
Interest Expense, Total
-352.7-398.4-561-352-173
Interest And Investment Income
--61213
Other Non Operating Expenses, Total
-0.317.725-46
EBT, Excl. Unusual Items
-3.520.253336679
Gain (Loss) On Sale Of Assets
-----
Other Unusual Items, Total
-38.1-38.9-25-11-25
EBT, Incl. Unusual Items
-79.6-51.911310639
EBT, Incl. Unusual Items Growth
-+34.8%+121.19%+2,718.18%+106.13%
EBT, Incl. Unusual Items Margin
-2.31%-1.36%0.27%6.98%12.19%
Income Tax Expense
4.645687926
Net Income to Company
-156.2-98.5-57231613
Minority Interest
1.9----
Net Income
-154.3-98.5-57231613
Net Income Growth
-+36.16%+42.13%+505.26%+165.37%
Net Income Margin %
-4.48%-2.58%-1.38%5.2%11.7%
Preferred Dividend and Other Adjustments
-----
Net Income to Common Excl. Extra Items
-82.3-96.9-57231613
Basic EPS - Continuing Operations
-0.02-0.02-0.240.972.6
Basic EPS - Continuing Operations Growth
--17.74%-1,184.57%+505.35%+167.39%
Diluted EPS - Continuing Operations
-0.02-0.02-0.240.972.58
Diluted EPS - Continuing Operations Growth
--18.75%-1,162.8%+504.28%+165.98%
Basic Weighted Average Shares Outstanding
5,187.75,187.7237.57237.52235.72
Diluted Weighted Average Shares Outstanding
5,187.75,187.7237.57237.79237
Dividend Per Share
---0.170.44
Dividend Per Share Growth
----+166.65%
EBITDA
567.36308188911,134
EBITDA Growth
-+11.05%+29.84%+8.92%+27.27%
EBITDA Margin %
16.47%16.48%19.87%20.07%21.64%
EBIT
349.5400.9606671885
* In Millions of USD (except for per share items)

FAQ

What was Galderma’s revenue at year end?

At the end of the last reported fiscal year, Galderma (GALD) recorded total revenue of 5,241.00 million USD.

How much revenue did Galderma report in the most recent quarter?

In its most recent quarterly earnings report, Galderma posted revenue of 3,148.00 million USD.

What was Galderma’s net income for the year?

For the full year, Galderma reported net income of 613.00 million USD.

How much net income did Galderma post in the last quarter?

In the most recent quarter, Galderma (GALD) posted net income of 444.00 million USD.

What was Galderma’s gross profit for the year?

Gross profit for the year was reported at 3,609.00 million USD.

How much gross profit did Galderma generate last quarter?

Galderma recorded gross profit of 2,210.00 million USD in its latest quarterly report.

What was Galderma’s annual operating income?

For the full year, Galderma (GALD) reported operating income of 885.00 million USD.

What was Galderma’s operating income last quarter?

Quarterly operating income was 637.00 million USD.

What was Galderma’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 801.00 million USD.

What was the quarter-over-quarter change in EBITDA for Galderma?

EBITDA changed by 32.84% million USD compared to the last quarter.

What is Galderma’s most recent gross profit margin?

The latest reported gross profit margin for Galderma (GALD) is 70.20% million USD.

What is Galderma’s most recent net income margin?

Net income margin based on recent financials is 14.10% million USD.

What is Galderma’s most recent EBIT margin?

Galderma reported an EBIT margin of 20.24% million USD based on current figures.

How did Galderma’s revenue change compared to the previous quarter?

Revenue changed by 13.44% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Galderma?

In the latest quarter, gross profit changed by 16.38% million USD from the previous quarter.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.